FDA cracks down on Hims & Hers for misleading weight loss medication ads

The Food and Drug Administration is targeting misleading promotional practices in pharmaceutical advertising, focusing on weight loss medications and telehealth services. Why it matters: This marks the first direct attempt by the FDA to police companies like Hims & Hers, which have long argued theyre not subject to traditional drug advertising rules. The details: The [] The post FDA cracks down on Hims & Hers for misleading weight loss medication ads appeared first on Techpinions.